Authors
Ying Gu, Jianhua Li
Published in
JACC. Case reports. Pages 110980. Nov 04, 2026. Epub Nov 04, 2026.
Abstract
Fluid overload-associated large B-cell lymphoma (FO-LBCL) is a rare malignancy presenting with serous effusions without solid masses.
We report an 83-year-old man developing substantial pericardial effusion 19 months post-left atrial appendage closure. Although a device-related complication was initially suspected, pericardial fluid analysis and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography established a definitive diagnosis of FO-LBCL. Because of severe cardiovascular comorbidities and anthracycline cardiotoxicity risks, standard rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone was contraindicated. Instead, an individualized, anthracycline-free regimen with 3 cycles of rituximab monotherapy followed by 3 cycles of rituximab, cyclophosphamide, vincristine, and prednisolone cycles was administered. The patient achieved remission and remained recurrence-free during 18-month follow-up.
The present case highlights the critical need to exclude malignancies in post-left atrial appendage closure effusions and demonstrates the efficacy of attenuated, anthracycline-free chemoimmunotherapy for elderly patients with FO-LBCL high cardiovascular risk.
PMID:
42980624
Bibliographic data and abstract were imported from PubMed on 04 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 12
- Comments 0